Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
0.3335
Dollar change
+0.0080
Percentage change
2.46
%
Index- P/E- EPS (ttm)-1.25 Insider Own20.58% Shs Outstand57.21M Perf Week-10.59%
Market Cap20.33M Forward P/E- EPS next Y-1.06 Insider Trans0.00% Shs Float48.42M Perf Month-92.93%
Income-68.88M PEG- EPS next Q-0.33 Inst Own62.03% Short Float1.25% Perf Quarter-93.84%
Sales1.68M P/S12.10 EPS this Y-0.63% Inst Trans-0.18% Short Ratio0.19 Perf Half Y-88.42%
Book/sh1.27 P/B0.26 EPS next Y16.72% ROA-58.52% Short Interest0.60M Perf Year-86.28%
Cash/sh1.43 P/C0.23 EPS next 5Y-1.60% ROE-95.93% 52W Range0.31 - 6.79 Perf YTD-93.64%
Dividend Est.- P/FCF- EPS past 5Y-21.63% ROI-62.13% 52W High-95.09% Beta-0.02
Dividend TTM- Quick Ratio4.78 Sales past 5Y58.51% Gross Margin15.25% 52W Low7.58% ATR (14)0.24
Dividend Ex-Date- Current Ratio4.78 EPS Y/Y TTM27.13% Oper. Margin-4270.18% RSI (14)13.37 Volatility9.19% 13.75%
Employees88 Debt/Eq0.49 Sales Y/Y TTM28.74% Profit Margin-4099.82% Recom2.60 Target Price5.17
Option/ShortYes / Yes LT Debt/Eq0.43 EPS Q/Q20.51% Payout- Rel Volume0.51 Prev Close0.33
Sales Surprise54.25% EPS Surprise-33.54% Sales Q/Q29.76% EarningsApr 30 AMC Avg Volume3.10M Price0.33
SMA20-77.35% SMA50-91.52% SMA200-91.91% Trades Volume1,593,535 Change2.46%
Date Action Analyst Rating Change Price Target Change
May-07-24Downgrade Jefferies Buy → Hold $10 → $0.50
May-07-24Downgrade H.C. Wainwright Buy → Neutral $12 → $2
May-07-24Downgrade BofA Securities Buy → Underperform
May-06-24Downgrade William Blair Outperform → Mkt Perform
Oct-06-23Resumed BTIG Research Buy $15
Aug-31-23Initiated H.C. Wainwright Buy $12
May-24-22Initiated Cantor Fitzgerald Overweight $15
May-26-20Initiated William Blair Outperform
May-26-20Initiated Jefferies Buy $24
May-26-20Initiated BTIG Research Buy $28
May-21-24 10:31AM
09:14AM
May-07-24 09:54AM
07:39AM
07:38AM
12:08PM Loading…
May-06-24 12:08PM
11:32AM
11:07AM
10:51AM
08:52AM
07:59AM
Apr-30-24 09:56PM
05:30PM
04:04PM
Apr-26-24 04:51PM
07:08AM Loading…
Mar-28-24 07:08AM
Mar-25-24 08:50AM
Mar-23-24 05:31AM
Mar-22-24 09:55AM
Mar-21-24 10:54PM
04:01PM
Mar-08-24 08:50AM
Mar-01-24 04:01PM
Feb-26-24 03:58AM
Feb-21-24 08:50AM
Jan-17-24 08:50AM
Nov-07-23 04:01PM
07:00AM
Oct-16-23 07:00AM
Sep-13-23 01:22PM
07:00AM Loading…
Sep-12-23 07:00AM
Sep-06-23 08:00AM
Aug-29-23 07:00AM
Aug-08-23 05:50PM
04:01PM
Jul-13-23 07:30AM
Jun-02-23 04:01PM
07:30AM
Jun-01-23 07:29AM
May-26-23 07:57AM
May-14-23 08:19AM
May-12-23 08:15AM
07:00AM
May-09-23 04:01PM
Apr-29-23 08:19AM
Apr-25-23 07:59AM
Mar-29-23 04:06PM
Mar-20-23 01:11PM
Mar-01-23 05:21AM
Feb-28-23 05:17AM
Feb-27-23 07:59AM
Feb-07-23 01:23PM
Feb-06-23 07:56AM
Jan-17-23 06:42PM
Dec-20-22 08:52AM
Nov-09-22 08:00AM
Nov-08-22 05:45PM
04:01PM
Sep-21-22 06:11AM
Sep-13-22 04:01PM
07:00AM
Sep-10-22 08:00AM
Sep-08-22 07:00AM
Sep-06-22 07:00AM
Aug-31-22 02:08PM
Aug-29-22 07:00AM
Aug-11-22 08:05AM
Aug-09-22 08:25AM
07:00AM
Jul-27-22 09:40AM
Jul-13-22 09:21AM
Jul-05-22 07:00AM
07:00AM
Jun-17-22 04:01PM
May-26-22 07:00AM
May-25-22 01:07PM
May-10-22 08:35AM
07:00AM
May-05-22 07:00AM
Apr-29-22 09:07AM
Apr-27-22 06:31AM
Apr-25-22 07:00AM
Apr-21-22 07:00AM
Apr-13-22 07:00AM
Apr-08-22 07:34AM
Mar-09-22 07:00AM
Mar-07-22 07:00AM
Mar-02-22 04:28AM
Feb-28-22 07:00AM
Feb-17-22 07:00AM
Jan-24-22 12:37PM
07:00AM
Nov-11-21 07:00AM
Nov-09-21 04:05PM
Nov-02-21 07:00AM
Oct-04-21 07:00AM
Sep-29-21 02:58PM
Sep-21-21 07:00AM
Sep-20-21 07:00AM
Sep-13-21 07:00AM
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Waksal HarlanExecutive ChairNov 10 '23Buy2.9625,00074,095261,966Nov 13 05:29 PM
PERCEPTIVE ADVISORS LLCDirectorMay 31 '23Buy2.493,610,8328,999,99911,469,117Jun 02 04:11 PM
ANDERSON EDWARD TDirectorMay 31 '23Buy2.431,805,4164,387,1612,521,745Jun 02 04:11 PM
NBVM GP, LLC10% OwnerMay 31 '23Buy2.431,805,4164,387,1612,521,745Jun 02 04:15 PM